Form-Fill-Seal
Investing in Form-Fill-Seal Technology
Lluc Mercadé
Grifols
PAP-Q1-2019-CL-011Apr 12, 2019
Outsourcing
Aligning the Outsourcing Relationship
Servier
PAP-Q1-2019-CL-006Apr 12, 2019
Commercialization
Adjusting Internal Structure to Better Meet Demands of Unmet Business
James E. Gregory
UPM Pharmaceuticals
PAP-Q1-2019-CL-009Apr 12, 2019
Formulation
Developing and Characterizing DPI Formulations for Biologics
Eunice Costa; Constança Cacela
Hovione
PAP-Q1-2019-CL-002Apr 12, 2019
Nice Insight Overview
Pharma Tackles the Big Issues
Nigel Walker
Nice Insight
PAP-Q1-2019-NI-003Mar 12, 2019
Supply Chain Solutions
Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma
Gulam Jaffer
Yourway
PAP-Q1-2019-CL-008Mar 12, 2019
Investment in Innovation
How Agile Investment Drives Innovation
Thibaut Fraisse
Fareva
PAP-Q1-2019-CL-004Mar 12, 2019
QPCR
Digital Droplet PCR for Viral Vector Analysis
Richard Snyder, Ph.D.; Susan D'Costa, Ph.D.; Sushma Ogram, Ph.D.; Diego Matayoshi
Thermo Fisher Scientific
PAP-Q1-2019-CL-005Mar 12, 2019
Viral Vectors
Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing
Jean Blehaut
Axplora
PAP-Q1-2019-CL-020Mar 12, 2019
HPAPI
Investing in the Future of Potent Compounds
Frederic Desdouits
Seqens
PAP-Q1-2019-CL-028Mar 12, 2019
Engineering
Leveraging Operational Simulations to Design Cell Therapy Facilities
Niranjan Kulkarni, Ph.D.
CRB USA
PAP-Q1-2019-CL-016Mar 12, 2019
CPhI & P-MEC China
A World of Opportunity: What to Expect from CPhI & P-MEC China
CPhI & P-MEC China
PAP-Q1-2019-CL-015Mar 12, 2019
Cell and Gene Therapy
Driving Growth of the Cell and Gene Therapy Sector
Felix Hsu
WuXi Advanced Therapies
PAP-Q1-2019-CL-012Mar 12, 2019
Drug Pricing
Balancing Ethical and Fiduciary Responsibilities in Drug Pricing
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q1-2019-NI-004Mar 12, 2019
Clinical Trials
Evolving Ethical Conduct Concerns in Clinical Trials
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q1-2019-NI-005Mar 12, 2019
Virtual Panel
Reprioritizing to Bring FY2020 into Focus
Sarath Chandar; Graeme MacLeod; Jeanne Thoma (former); Joe Rogus; John Creighton; Coralyn Gonzalez; Jon Struthers
SPI Pharma
PAP-Q1-2019-CL-032Mar 12, 2019
Benefitting U.S. Clients
Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position
Federico Pollano
Rentschler Biopharma SE
PAP-Q1-2019-CL-033Mar 12, 2019
Attracting Investment
Preparing Middle-Market Firms to Attract Investment
Jeffrey Marlough
Castleford Capital
PAP-Q1-2019-CL-007Mar 12, 2019
Facility Sales
Setting Expectations for Facility and Business Sales in the CDMO Sector
William B. Wiederseim
PharmaBioSource, Inc.
PAP-Q1-2019-CL-001Mar 12, 2019
Meet the Investor
Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider
David Q. Anderson
Ampersand Capital Partners
PAP-Q1-2019-CL-024Mar 12, 2019